Literature DB >> 23001690

The N-terminus of vaccinia virus host range protein C7L is essential for function.

Masanori Terajima1, Stina L Urban, Anita M Leporati.   

Abstract

Vaccinia virus (VACV), a member of the Poxviridae family of large double-stranded DNA viruses, is being used as a smallpox vaccine as well as an expression vector for immunization against other infectious diseases and cancer. The host range of wild type VACV is very broad among mammalian cells. C7L is a host range gene identified in VACV and is well conserved in mammalian poxviruses except for parapoxviruses and molluscum contagiosum virus. The molecular mechanisms by which the C7L gene exerts host range function are not well understood. The C7L protein does not have any known conserved domains or show sequence similarity to cellular proteins or viral proteins other than the C7L homologs in mammalian poxviruses. We generated recombinant vaccinia viruses carrying deletion mutants of the C7L gene using NYVAC as a parental strain and found that the N-terminus is essential for host range function of C7L, which is consistent with a previous report that showed that homology among C7L homologs are greater near the N-terminus than the C-terminus.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23001690      PMCID: PMC3546155          DOI: 10.1007/s11262-012-0822-x

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.198


  25 in total

1.  Downregulation of vaccinia virus intermediate and late promoters by host transcription factor YY1.

Authors:  Bruce A Knutson; Jaewook Oh; Steven S Broyles
Journal:  J Gen Virol       Date:  2009-03-18       Impact factor: 3.891

2.  Yeast two-hybrid cloning of a novel zinc finger protein that interacts with the multifunctional transcription factor YY1.

Authors:  J L Kalenik; D Chen; M E Bradley; S J Chen; T C Lee
Journal:  Nucleic Acids Res       Date:  1997-02-15       Impact factor: 16.971

3.  Generation of recombinant vaccinia viruses expressing Puumala virus proteins and use in isolating cytotoxic T cells specific for Puumala virus.

Authors:  Masanori Terajima; Heather L Van Epps; Dexin Li; Anita M Leporati; Sarah E Juhlin; Jukka Mustonen; Antti Vaheri; Francis A Ennis
Journal:  Virus Res       Date:  2002-03-20       Impact factor: 3.303

4.  Localization and sequence of a vaccinia virus gene required for multiplication in human cells.

Authors:  S Gillard; D Spehner; R Drillien; A Kirn
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

Review 5.  Fighting cancer with vaccinia virus: teaching new tricks to an old dog.

Authors:  Yuqiao Shen; John Nemunaitis
Journal:  Mol Ther       Date:  2005-02       Impact factor: 11.454

Review 6.  Transcription factor YY1: structure, function, and therapeutic implications in cancer biology.

Authors:  S Gordon; G Akopyan; H Garban; B Bonavida
Journal:  Oncogene       Date:  2006-02-23       Impact factor: 9.867

7.  M062 is a host range factor essential for myxoma virus pathogenesis and functions as an antagonist of host SAMD9 in human cells.

Authors:  Jia Liu; Sonia Wennier; Leiliang Zhang; Grant McFadden
Journal:  J Virol       Date:  2011-01-19       Impact factor: 5.103

8.  Poxvirus genomes: a phylogenetic analysis.

Authors:  Caroline Gubser; Stéphane Hué; Paul Kellam; Geoffrey L Smith
Journal:  J Gen Virol       Date:  2004-01       Impact factor: 3.891

9.  Kinetic analysis of a complete poxvirus transcriptome reveals an immediate-early class of genes.

Authors:  Erika Assarsson; Jason A Greenbaum; Magnus Sundström; Lana Schaffer; Jennifer A Hammond; Valerie Pasquetto; Carla Oseroff; R Curtis Hendrickson; Elliot J Lefkowitz; David C Tscharke; John Sidney; Howard M Grey; Steven R Head; Bjoern Peters; Alessandro Sette
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-01       Impact factor: 11.205

10.  Identification from diverse mammalian poxviruses of host-range regulatory genes functioning equivalently to vaccinia virus C7L.

Authors:  Xiangzhi Meng; Jie Chao; Yan Xiang
Journal:  Virology       Date:  2007-12-03       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.